Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,633
Closed -$303K 2963
2019
Q3
$303K Buy
+6,633
New +$289K ﹤0.01% 2179
2018
Q1
Sell
-8,503
Closed -$238K 2679
2017
Q4
$238K Buy
+8,503
New +$260K ﹤0.01% 2127
2015
Q3
Sell
-1,721
Closed -$40K 2963
2015
Q2
$40K Buy
+1,721
New +$43.2K ﹤0.01% 2501

Other funds holding SRDX

Jefferies Group's SRDX Position: Q4 2019 in Review

Jefferies Group sold out of Surmodics (SRDX) in Q4 2019, closing a stake of 6,633 shares — an estimated $303K sold.

Jefferies Group first reported a position in SRDX in Q2 2015 and held it in 3 quarters. The position peaked at $303K in Q3 2019. 143 funds tracked by Wall St. Rank hold SRDX as of Q4 2019.

  • Jefferies Group reported no remaining Surmodics position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 6,633 Surmodics shares in Q4 2019, an estimated $303K.
  • Jefferies Group first reported a position in Surmodics in Q2 2015 and held it in 3 quarters.
  • Jefferies Group's Surmodics position peaked at $303K in Q3 2019.
  • 143 funds tracked by Wall St. Rank held Surmodics as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.